.
BioEnterprise

Cleveland HeartLab Receives Investment from Advantage Capital Partners

Cleveland HeartLab, provider of blood and biomarker testing that determines cardiovascular risk, received funding from Advantage Capital Partners. The company plans to use the funding to focus on growth opportunities.

Read More  >